Global reprogramming of the cellular translational landscape facilitates cytomegalovirus replication

Cell Reports

Volumn 6, Issue 1, 2014, Pages 9-17

  McKinney, Caleb ^a   Zavadil, Jiri ^a   Bianco, Christopher ^a   Shiflett, Lora ^a   Brown, Stuart ^a   Mohr, Ian ^a  

^a NEW YORK UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GLYCOGEN SYNTHASE KINASE 3ALPHA; GLYCOGEN SYNTHASE KINASE 3BETA; INITIATION FACTOR; INITIATION FACTOR 4F; INITIATION FACTOR 6; MAMMALIAN TARGET OF RAPAMYCIN COMPLEX 1; PHOSPHOPROTEIN PHOSPHATASE 1; PHOSPHOPROTEIN PHOSPHATASE 1 ALPHA; POLYADENYLIC ACID BINDING PROTEIN; STAT3 PROTEIN; TRANSCRIPTION FACTOR E2F1; UNCLASSIFIED DRUG; VIRUS PROTEIN; VIRUS UL38 PROTEIN;

ARTICLE; CELL DIFFERENTIATION; CELLULAR TRANSLATIONAL LANDSCAPE; CELLULAR, SUBCELLULAR AND MOLECULAR BIOLOGICAL PHENOMENA AND FUNCTIONS; CONTROLLED STUDY; DISEASE ASSOCIATION; GENE FUNCTION; GENE REPRESSION; GENOME; HUMAN; HUMAN CELL; HUMAN CYTOMEGALOVIRUS; IMMUNE RESPONSE; NONHUMAN; NUCLEAR REPROGRAMMING; POLYSOME; PRIORITY JOURNAL; PROTEIN DEPLETION; PROTEIN EXPRESSION; PROTEIN INDUCTION; STEADY STATE; TRANSLATION INITIATION; TRANSLATION REGULATION; VIROGENESIS; VIRUS REPLICATION;

CYTOMEGALOVIRUS; HUMAN HERPESVIRUS 5;

CAPSID PROTEINS; CELL LINE; CYTOMEGALOVIRUS; FIBROBLASTS; HUMANS; POLYRIBOSOMES; PROTEIN BIOSYNTHESIS; RNA, MESSENGER; VIRUS REPLICATION;

EID: 84892533073     PISSN: None     EISSN: 22111247     Source Type: Journal    
DOI: 10.1016/j.celrep.2013.11.045     Document Type: Article

References (37)

1. Badura M., Braunstein S., Zavadil J., Schneider R.J. DNAdamage and eIF4G1 in breast cancer cells reprogram translation for survival and DNA repair mRNAs. Proc. Natl. Acad. Sci. USA 2012, 109:18767-18772.
2. Bilanges B., Argonza-Barrett R., Kolesnichenko M., Skinner C., Nair M., Chen M., Stokoe D. Tuberous sclerosis complex proteins 1 and 2 control serum-dependent translation in a TOP-dependent and -independent manner. Mol. Cell. Biol. 2007, 27:5746-5764.
3. Dziurzynski K., Chang S.M., Heimberger A.B., Kalejta R.F., McGregor Dallas S.R., Smit M., Soroceanu L., Cobbs C.S. Consensus on the role of human cytomegalovirus in glioblastoma. Neuro-oncol. 2012, 14:246-255. HCMV and Gliomas Symposium.
4. Hakki M., Geballe A.P. Cellular serine/threonine phosphatase activity during human cytomegalovirus infection. Virology 2008, 380:255-263.
5. Hsieh A.C., Liu Y., Edlind M.P., Ingolia N.T., Janes M.R., Sher A., Shi E.Y., Stumpf C.R., Christensen C., Bonham M.J., et al. The translational landscape of mTOR signalling steers cancer initiation and metastasis. Nature 2012, 485:55-61.
6. Huang W., Sherman B.T., Lempicki R.A. Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources. Nat. Protoc. 2009, 4:44-57.
7. Irizarry R.A., Bolstad B.M., Collin F., Cope L.M., Hobbs B., Speed T.P. Summaries of Affymetrix GeneChip probe level data. Nucleic Acids Res. 2003, 31:e15.
8. Kobayashi M., Wilson A.C., Chao M.V., Mohr I. Control of viral latency in neurons by axonal mTOR signaling and the 4E-BP translation repressor. Genes Dev. 2012, 26:1527-1532.
9. Kudchodkar S.B., Yu Y., Maguire T.G., Alwine J.C. Human cytomegalovirus infection induces rapamycin-insensitive phosphorylation of downstream effectors of mTOR kinase. J.Virol. 2004, 78:11030-11039.
10. Larsson O., Morita M., Topisirovic I., Alain T., Blouin M.J., Pollak M., Sonenberg N. Distinct perturbation of the translatome by the antidiabetic drug metformin. Proc. Natl. Acad. Sci. USA 2012, 109:8977-8982.
11. Lee A.S.-Y., Burdeinick-Kerr R., Whelan S.P.J. A ribosome-specialized translation initiation pathway is required for cap-dependent translation of vesicular stomatitis virus mRNAs. Proc. Natl. Acad. Sci. USA 2013, 110:324-329.
12. Loreni F., Mancino M., Biffo S. Translation factors and ribosomal proteins control tumor onset and progression: how?. Oncogene 2013, 10.1038/onc.2013.153.
13. Mamane Y., Petroulakis E., Martineau Y., Sato T.A., Larsson O., Rajasekhar V.K., Sonenberg N. Epigenetic activation of a subset of mRNAs by eIF4E explains its effects on cell proliferation. PLoS ONE 2007, 2:e242.
14. McKinney C., Perez C., Mohr I. Poly(A) binding protein abundance regulates eukaryotic translation initiation factor 4F assembly in human cytomegalovirus-infected cells. Proc. Natl. Acad. Sci. USA 2012, 109:5627-5632.
15. McKinney C., Yu D., Mohr I. A new role for the cellular PABP repressor Paip2 as an innate restriction factor capable of limiting productive cytomegalovirus replication. Genes Dev. 2013, 27:1809-1820.
16. Meyuhas O. Synthesis of the translational apparatus is regulated at the translational level. Eur. J. Biochem. 2000, 267:6321-6330.
17. Mohr I., Sonenberg N. Host translation at the nexus of infection and immunity. Cell Host Microbe 2012, 12:470-483.
18. Moorman N.J., Cristea I.M., Terhune S.S., Rout M.P., Chait B.T., Shenk T. Human cytomegalovirus protein UL38 inhibits host cell stress responses by antagonizing the tuberous sclerosis protein complex. Cell Host Microbe 2008, 3:253-262.
19. Park E.-H., Zhang F., Warringer J., Sunnerhagen P., Hinnebusch A.G. Depletion of eIF4G from yeast cells narrows the range of translational efficiencies genome-wide. BMC Genomics 2011, 12:68. 10.1186/1471-2164-12-68.
20. Parsyan A., Svitkin Y., Shahbazian D., Gkogkas C., Lasko P., Merrick W.C., Sonenberg N. mRNA helicases: the tacticians of translational control. Nat. Rev. Mol. Cell Biol. 2011, 12:235-245.
21. Perez C., McKinney C., Chulunbaatar U., Mohr I. Translational control of the abundance of cytoplasmic poly(A) binding protein in human cytomegalovirus-infected cells. J.Virol. 2011, 85:156-164.
22. Qian Z., Xuan B., Gualberto N., Yu D. The human cytomegalovirus protein pUL38 suppresses endoplasmic reticulum stress-mediated cell death independently of its ability to induce mTORC1 activation. J.Virol. 2011, 85:9103-9113.
23. Saeed A.I., Sharov V., White J., Li J., Liang W., Bhagabati N., Braisted J., Klapa M., Currier T., Thiagarajan M., et al. TM4: a free, open-source system for microarray data management and analysis. Biotechniques 2003, 34:374-378.
24. Silvera D., Formenti S.C., Schneider R.J. Translational control incancer. Nat. Rev. Cancer 2010, 10:254-266.
25. Söderberg-Nauclér C. HCMV microinfections in inflammatory diseases and cancer. J.Clin. Virol. 2008, 41:218-223.
26. Soroceanu L., Cobbs C.S. Is HCMV a tumor promoter?. Virus Res. 2011, 157:193-203.
27. Stanton R.J., McSharry B.P., Rickards C.R., Wang E.C., Tomasec P., Wilkinson G.W. Cytomegalovirus destruction of focal adhesions revealed in a high-throughput Western blot analysis of cellular protein expression. J.Virol. 2007, 81:7860-7872.
28. Stern-Ginossar N., Weisburd B., Michalski A., Le V.T., Hein M.Y., Huang S.X., Ma M., Shen B., Qian S.B., Hengel H., et al. Decoding human cytomegalovirus. Science 2012, 338:1088-1093.
29. Stinski M.F. Synthesis of proteins and glycoproteins in cells infected with human cytomegalovirus. J.Virol. 1977, 23:751-767.
30. Tanaka S., Furukawa T., Plotkin S.A. Human cytomegalovirus stimulates host cell RNA synthesis. J.Virol. 1975, 15:297-304.
31. Terhune S., Torigoi E., Moorman N., Silva M., Qian Z., Shenk T., Yu D. Human cytomegalovirus UL38 protein blocks apoptosis. J.Virol. 2007, 81:3109-3123.
32. Thoreen C.C., Chantranupong L., Keys H.R., Wang T., Gray N.S., Sabatini D.M. A unifying model for mTORC1-mediated regulation of mRNA translation. Nature 2012, 485:109-113.
33. Topisirovic I., Sonenberg N. mRNA translation and energy metabolism in cancer: the role of the MAPK and mTORC1 pathways. Cold Spring Harb. Symp. Quant. Biol. 2011, 76:355-367.
34. Virshup D.M., Shenolikar S. From promiscuity to precision: protein phosphatases get a makeover. Mol. Cell 2009, 33:537-545.
35. Walsh D., Mohr I. Viral subversion of the host protein synthesis machinery. Nat. Rev. Microbiol. 2011, 9:860-875.
36. Walsh D., Perez C., Notary J., Mohr I. Regulation of the translation initiation factor eIF4F by multiple mechanisms in human cytomegalovirus-infected cells. J.Virol. 2005, 79:8057-8064.
37. Xue S., Barna M. Specialized ribosomes: a new frontier in gene regulation and organismal biology. Nat. Rev. Mol. Cell Biol. 2012, 13:355-369.